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High-field proton (‘H) nuclear magnetic resonance (NMR) spectroscopy has been employed to evaluate the formation of substance P carbamate 
in aqueous solution. Equilibration of substance P with physiologxally relevant concentrations of bicarbonate (2.50 x lo-’ mol.dm-3) at pH 7.00 
generated a new multiplet signal centred at 4.13 ppm in its NMR spectrum, characteristic of the a-proton of pepttde carbamate species. High-field 
‘H NMR spectroscopy also demonstrated that the model dipeptide, ArggGly, formed a carbamate in neutral aqueous soluttons contaming 
2.50 x lo-’ mol.dmm3 HCO,-. The phystological sigmficance of these results is discussed in view of the central roles of vasoacttve neuropeptides 
in human jomt diseases and the hypercapmc environment of the inflamed rheumatoid joint. 
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1. INTRODUCTION 
Substance P is a member of the tachykinin family of 
peptides and is localised within small primary sensory 
neurones throughout the body [l]. Currently, there is 
strong evidence to suggest that it serves to regulate the 
inflammatory response to a variety of stimuli [2]. More- 
over, substance P interacts with a specific NK-1 recep- 
tor present on several cell types, including vascular 
smooth muscle and endothelial cells. Intra-dermal injec- 
tions of substance P into human skin result in hyperal- 
gesia, vasodilatation and plasma extravasation [3]. It 
also appears to play a wider role in immunoregulation, 
and in vitro studies have shown significant interactions 
with neutrophils, lymphocytes. macrophages and syno- 
viocytes [4]. 
Recent reports indicate that human and experimental 
joint diseases have an important neurogenic component 
in which substance P plays a pivotal role [4]. Injections 
of substance P into minimally involved joints increases 
the severity of disease therein, and substance P antago- 
nists significantly inhibit the early articular responses to 
inflammatory agents, such as carrageenin. 
For many years it has been recognised that impair- 
ment of the vascular supply to the inflamed rheumatoid 
joint and/or an elevation in its metabolic rate gives rise 
to the markedly abnormal metabolic status of the intra- 
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articular environment. Previous investigations of the 
physiological status of the inflamed joint have estab- 
lished an extremely low synovial fluid oxygen tension 
[5,6], increased carbon dioxide tension, diminished glu- 
cose concentrations, substantially elevated lactate levels 
and an associated acidosis [7-111. Indeed, Falchuck et 
al. [7] have previously demonstrated that joints exhibit- 
ing severe microvascular destruction in the synovial 
membrane had the lowest PO,, were substantially hy- 
percapnic (high pCOz), and contained high concentra- 
tions of lactate. 
In view of the hypercapnic environment of the in- 
flamed rheumatoid joint, it is conceivable that certain 
neuropeptides form carbamate species in this environ- 
ment. Such carbamate production may play an impor- 
tant role in influencing the biological activity of neu- 
ropeptides, e.g. the modulation or elevation of their 
capacity to bind to protein receptors located on cellular 
membranes. The generation of amino acid, peptide and 
protein carbamates from the reaction of CO, with a free 
amino functional group (Eq. 1) in moderately basic so- 
lution has been known for many years [12-141 and is a 
phenomenon that has stimulated much biochemical in- 
terest since carbamate formation by 
R-NH, + CO, = R-NHCOI- + H’ (1) 
polypeptides is an important mechanism involved in the 
transport of CO, from respiring tissues [14,15]. Indeed. 
considerable quantities of CO, are bound to haemo- 
globin and plasma proteins in this manner [15], and the 
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dipeptide glycylglycine has been employed as a model 
for these reactions [ 13.161. 
Our interest in the pathological roles of substance P 
in inflammatory joint diseases has led us to investigate 
the nature and level of carbamate formation for this 
vasoactive undecapeptide in neutral aqueous solution 
using high-field proton (‘H) nuclear magnetic resonance 
(NMR) spectroscopy. Proton NMR spectroscopy is a 
technique which is particularly suited to the study of 
carbamate production since the assignment of amino 
acid a-carbamate resonances is facile [17]. Moreover, it 
should also be noted that a revived current interest in 
the physiological significance of carbamate formation 
has arisen from their artifactual generation during the 
preparation of biofluids in bicarbonate buffers for mul- 
ticomponent analysis by this technique [ 18,191. 
2. MATERIALS AND METHODS 
3.1 Sun2plr prepurutwn and trratrrzent 
Substance P was obtained from Cambrrdge Research Btochemtcals 
(ICI. UK) and the dipeptldr, Arg-Gly, was purchased from Stgma 
Chemical Co. (UK). 99.9% (v/c) ‘H,O was obtamed from Goss Scien- 
ttfic Ltd. (UK). Solutrons of substance P (3.71 x lO_’ mol.dm-‘) and 
Arg-Gly (2.50 x l@-” mol.dm-‘) m ‘H,O were adjusted to pH 7.00 
(meter reading) with ‘HCI and NaO’H solutrons m ‘H,O prior to ‘H 
NMR analysis. Subsequently these solutions were treated with 
2.50 x lo-’ mol,dm--’ NaHCO,, and therr pH values further adjusted 
to 7.00. ‘H NMR spectra of these HCO,--treated peptide solutions 
were acquned following equihbration at ambtent temperature for pe- 
roods of 30 mm (substance P and Arg-Gly), 48 h (substance P) and 
10 days (Arg--Gly). 
2.2. ‘H NMR JprctroscopJ 
‘H NMR spectra were obtained from samples u-r 5 mm o.d. tubes 
using Bruker WH-400 and AMXdOO NMR spectrometers operatmg 
at 400 and 600 MHz, respectrvely. Spectra were acqmred in the pulse- 
Fourier transform mode and are referenced to external trimethylsilyl- 
(2,2,3,3-‘HJpropionate (TSP). Typrcally up to 8,000 transients. each 
mto 32k data pomts, were accumulated for each spectrum usmg a 45’ 
flip angle pulse with a data acquisition time of ca. 3 5 s. Pre-rrradation 
of the solvent residual ‘HOH signal for 2 5 s prior to each scan was 
employed to reduce the mtensrty of thus resonance in the final spec- 
trum. These long accumulation times were necessrtated since the pre- 
irradiation was mamtained at a low-power level in order to mmlmise 
the saturatron of neighbouring a-CH resonances 
3. RESULTS 
Since the N-terminus of substance P is Arg-Pro-, the 
dipeptide, Arg-Gly, was primarily utilised as a simple. 
commercially available model compound for evaluating 
substance P-CO, interactions. The use of dipeptides as 
models for more complex peptides and proteins has 
much precedence in view of previous investigations by 
Roughton and Rossi-Bernardi [30] in which glycyl- 
glycine was employed to model carbamate formation in 
haemoglobin. The evaluation of model dipeptide car- 
bamate production has particular advantages which are 
especially relevant to high-field NMR analysis since 
spectra are greatly simplified and CO,-mediated modify- 
cations therein are readily detectable. 
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The 400 MHz ‘H NMR spectrum of a 2.50 x lo-’ 
mol.dm-’ solution of Arg-Gly in ‘H,O (Fig. la) in- 
cludes a tripIet resonance located at 3.98 ppm which is 
assignable to the cl-proton of the arginyl component, 
and full assignments for this spectrum are given in Table 
I. The pKa value of the arginyl a-amino group is likely 
to be close to 8.2 (cf. ArggAla”), giving rise to ca. 
lo-20% deprotonation of this primary a-amine func- 
tion at physiological pH values. Subsequent to the addi- 
tion of aqueous NaHCO, (2.50 x lo-’ moledm-‘), a new 
resonance centred at 4.08 ppm is generated in the spec- 
trum (Fig. lb). Although incompletely resolved, this 
signal appears to be a multiplet which, by analogy with 
previous investigations [ 22-241 is assignable to the CL- 
proton of this dipeptide’s carbamate adduct. This reso- 
nance appeared within 30 min of HCO,- addition, and 
was detectable in samples which were > 7 days old. 
Carbamate formation in this dipeptide also gave rise to 
a downfield shift in the position of the a-CH proton 
triplet. The terminal side-chain primary amine func- 
tional group of arginine is known to be quite resistant 
to carbamate production at neutral pH values [13] (pKa 
value ca. 10). 
The generation of substance P carbamate in aqueous 
solution was also investigated by high-field NMR spec- 
troscopy. A previous ‘H NMR study of substance P has 
shown that the peptide is largely aggregated in aqueous 
solution at extremes of pH (i.e. < 2 and > 9) [25] but 
that there is little or no aggregation at around pH 7.0, 
the pH used in this study. Chassaing et al. [26] used ‘H 
NMR in their study of the solvent dependence of sub- 
stance P conformations: in particular they assigned the 
‘E-I resonances in ‘H,O solution at pD = 2.5. Our sam- 
ples were at pH 7.00, and therefore the ‘H spectrum was 
re-investigated to check for a significant change in the 
‘H chemical shifts between these two pH values. This 
re-assignment used COSY and TOCSY homonuclear 
two-dimensional ‘H spectra (described, for example, by 
Gray [27]) measured at 600 MHz. The ‘H chemical 
Table I 
‘H NMR data for Arg-Gly and Arg-Gly carbamate 
6 Assrgnment Compound 
1.70 (m) 
1.92 (m) 
3.26 (t) 
3.98 (t) 
3.80 (d) 
3.85 (d) 
Arg y-CHz 
Arg /?-CH, 
Arg S-CH? 
Arg cl-CH 
Gly a-CH 
Gly-a-CH’ 
Arg-Gly 
4.03 (m) Arg a-CH Arg-Gly carbamate 
The sample consisted of a 1.5 x lo-’ mol,dm-’ solution of ArggGly in 
‘Hz0 at pH 7.0. The carbamate was formed by the additton of 
2.5 x lo-’ mol.dm-’ NaHCO,. The chemical shafts (6) are m ppm wtth 
reference to high frequency external trtmethylsilyl-(2,2,3,3-?H,)-propr- 
onate (TSP) The letters in parentheses indicate the multiplicity of the 
resonances: d. doublet: t. trrplet; m, multtplet. 
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shifts measured in this study parallel those reported by 
Chassaing et al. [26] except that our shifts consistently 
have ca. 0.1 ppm higher frequency, a result of the differ- 
ence in the external chemical shift reference substance 
(TSP here, tetramethylsilane in [26]). The only signifi- 
cant difference in relative chemical shifts is that, for the 
higher pH used here, the Arg’ a-CH resonance has ca. 
0.07 ppm lower frequency and overlaps with a-CH res- 
onances from Gln5 and Gln6. 
The partial ‘H spectrum of a 3.71 x low3 mol.dm-3 
solution of substance P in ‘H,O (pH 7.00) with corre- 
sponding resonance assignments is shown in Fig. 2a. 
Equilibration of this substance P solution with 
2.50 x lo-’ mol.dmm3 HCO,- for a 30 min period (final 
pH 7.00) generated a new, relatively broad resonance at 
4.13 ppm in the spectrum, a chemical shift value which 
is very close to that of the a-proton signal of amino acid 
carbamates [22]. Further HCO,--mediated modifica- 
tions in the spectrum were also observed, including a 
downfield shift of ca. 0.1 ppm for the multiplets centred 
at 4.24 and 4.42 ppm in the spectrum of the untreated 
neuropeptide. Subsequent to further equilibration at 
ambient temperature (48 h), the carbamate signal ap- 
peared as a partially resolved multiplet located at 4.04 
ppm. The chemical shift value of this carbamate reso- 
b 
ppm 3.5 
Fig. 1. Partial 400 MHz ‘H NMR spectra of a 2.50 x lo-’ mol dm-’ 
solution of the ArggGly dipeptide m ‘H,O at pH 7.00 (a) pnor and 
(b) subsequent to equilibration with 2.50 x lo-’ mol.dm-3 HCO,- at 
ambient temperature for 30 min. The arrow in spectrum b indicates 
the a-proton resonance of the dipeptide’s carbamate adduct. 
a 
I I I 
4.0 ppm 3.5 3.0 
Fig. 2. Partial 400 MHz ‘H NMR spectra of a 3.71 x 10ml mol,dm-’ 
solutton of substance P in ‘H,O at pH 7.00 (a) before and (b) after 
equilibration with 2.50 x lo-’ mohdm-’ HCO,- at ambient tempera- 
ture of a period of 30 mm. The arrow in spectrum b indicates the 
a-proton resonance of the pepttde’s carbamate species. 
nance is virtually identical to that of the Arg-Gly dipep- 
tide, and provides further evidence for carbamate gener- 
ation in substance P under these experimental condi- 
tions. 
The likely significance of substance P carbamate for- 
mation under physiological conditions can be judged 
from Fig. 3, in which the specification of a peptide at 
biologically relevant concentrations of bicarbonate has 
been modelled. The model uses a value of 8.00 for the 
pKa of the terminal amine functional group. The inter- 
action of CO, with amine functional groups is usually 
defined in terms of an equilibrium constant Kc expressed 
in Eq. 2. In this equation the pKc value of the depro- 
tonated amine function has been set to a value of 4.5. 
K = [RNHCO,-1 [H’l 
c 
tRNH21 WJ 
(2) 
4. DISCUSSION 
Neurogenic inflammatory responses involving sub- 
stance P have undoubtedly evolved as a protective 
mechanism and are likely to be involved in tissue repair. 
Under normal conditions, substance P may serve to 
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Fig. 3. Graphical representation of the extent of carbamate production 
for a typical peptlde expressed as a function of physlologlcal relevant 
HCO,- concentrations. 
initiate or modulate the inflammatory response to nox- 
ious stimuli, ans diminishing levels of this neuropeptide 
may have deleterious effects on regulation of the inflam- 
matory cascade. Indeed, it is conceivable that some as- 
pects of the immune dysregulation seen in chronic ar- 
thritis arise from the depletion of neuropeptides such as 
substance P. 
The High-field ‘H NMR data presented here provide 
much evidence for the reactions of the terminal cl-amine 
functional groups of both substance P and the model 
dipeptide, Arg-Gly. with physiologically relevant con- 
centrations of bicarbonate to form a-carbamate species. 
Since the estimated pKa value of the arginyl a-amino 
function in the parent peptide is ca. 8.2, the generation 
of carbamate species from substance P and Arg-Gly is 
not unexpected at physiologically relevant pH values. 
The production of substance P carbamates in the hy- 
percapnic environment of the inflamed rheumatoid 
joint is likely to be of much significance in view of 
previous reports that the diamino acids, a,y-diami- 
nobutyrate and a,/?-diaminopropionate, exhibit neuro- 
toxic behaviour only in the presence of bicarbonate [28]. 
Moreover, the neurotoxicity of L-cysteine. both in vivo 
and in vitro, is bicarbonate-dependent and mediated by 
N-methyl aspartate receptors [29]. Formation of the 
corresponding carbamates of these amino acids and 
peptides provides a plausible explanation for such activ- 
ity. Indeed, L-cysteine readily forms an a-carbamate 
species, a phenomenon demonstrable by ‘H and 13C 
NMR spectroscopy [24,30]. 
252 
The generation of substance P a-carbamate in vivo 
may consequently exert an important influence on the 
vasoactivity of this neuropeptide which appears to play 
a critical role in inflammatory joint diseases. and we are 
currently investigating the ability of increasing concen- 
trations of bicarbonate to influence its binding to cell 
surface receptors. 
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